Sponsor Pipeline

Black Diamond Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07326566 Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With… Glioblastoma (GBM) Recruiting
Phase 1/2
NCT05256290 Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small… Non-Small Cell Lung Cancer Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Glioblastoma (1) Glioma (1)
Get alerts when Black Diamond Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free